KLING DOUGLAS F (Chief Operating Officer) sold 27.3% of their position (16.54K shares) of NEWAMSTERDAM PHARMA CO N.V. on the open market
Insider sale on the open market — a significant reduction. Check remaining position size for full context.
S · 1 sale
Filed: 3/28/2025ACC: 0000950170-25-046943
Officer· Chief Operating Officer
Since Dec 2023
0.00
Net shares
Net seller
$0.00
Total acquired
1
Open market trades
0B · 1S
4
Total transactions
33.08K acquired · 33.08K disposed
Non-Derivative Transactions2
Ordinary Shares
Direct
Shares
+16.54K
Price / share
—
Trade value
—
% of position
37.6%
3/26/2025
44K→60.54K
Ordinary Shares
Direct
Shares
−16.54K
Price / share
—
Trade value
—
% of position
27.3%
3/26/2025
60.54K→44K
Total
Net shares
+0.00
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 3/26/2025 | M · Option Exercise | +16.54K | — | — | 37.6% | 44K | 60.54K |
| Ordinary Shares Direct | 3/26/2025 | S · Sale | −16.54K | — | — | 27.3% | 60.54K | 44K |
| Total | +0.00 | $0.00 | ||||||
Derivative Transactions2
Restricted Stock Unit
Direct
Converts to
Ordinary Shares
16.54K shares
Shares
+16.54K
Strike price
Held after
16.54K
Exercisable
—
3/26/2025
Restricted Stock Unit
Direct
Converts to
Ordinary Shares
16.54K shares
Shares
−16.54K
Strike price
Held after
0.00
Exercisable
—
3/26/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Unit Direct | Ordinary Shares16.54K shares | 3/26/2025 | A · Award | +16.54K | — | 16.54K | |
| Restricted Stock Unit Direct | Ordinary Shares16.54K shares | 3/26/2025 | M · Option Exercise | −16.54K | — | 0.00 |